Novo NordiskNVO undercut Eli LillyLLY and the Trump administration on Monday, slashing the cash price of its drugs Wegovy and Ozempic to just $349 a month. That compares with $499 a month, previously, ...

WHO issues 1st guideline on GLP-1s recommending long-term use with behavioral therapy and notes pricing changes from major manufacturers.

Novo Nordisk makes the popular weight loss drug Wegovy. The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their weight loss ...

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal with the Trump administration to drop prices for customers. The Wegovy ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

The U.S. Food and Drug Administration approved the drug Zepbound to treat obesity on Wednesday. The drug's active ingredient is called tirzepatide. As a diabetes drug, it is sold under the brand name ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

The Food and Drug Administration is set to treat the application under its priority program to accelerate the review of ...